KANSAS CITY, Kan., Feb. 03, 2016 -- Epiq (NASDAQ:EPIQ), a leading global provider of integrated technology solutions and services for the legal profession, today announced an enhanced corporate managed services offering to address the specific challenges corporate clients face when conducting eDiscovery.
ArcSM—Epiq’s managed services platform that gives clients their own Relativity® environment for a fixed monthly fee—has long been adopted within law firms and has become increasingly popular among corporate legal departments. In response to requests from corporate clients, Epiq added new features within the Arc platform to address the needs of corporations.
Arc is now equipped with cross-matter reporting, which gives clients the ability to run reports across multiple cases. This aspect of Arc gives users a bird’s-eye view on data storage allocation, reviewer performance and the review environment as a whole.
Users can save multiple dashboards, cuts and views, and can report by case, law firm, jurisdiction, matter type, or all four. The Arc platform also offers project and custodian tracking that links eDiscovery activity to data from a corporation’s matter management application or legal hold system and provides data that ties projects and custodians from these systems through processing to hosting and review.
“Corporations today face more litigation and eDiscovery pressure than ever before,” said Andrew Shimek, managing director, eDiscovery. “Managed services delivered via our Arc platform helps ease that burden by providing inside counsel teams the ability to forecast and control costs.”
In addition, Epiq’s HorizonSM processing workflow application can now merge chat and audio data with other eDiscovery data and combine it in the Arc platform. Chat and audio discovery tools are often of particular interest to financial institutions that are required by law to record all their phone transactions, or corporations that routinely use chat applications.
About Epiq
Epiq (NASDAQ:EPIQ) is a leading global provider of integrated technology and services for the legal profession, including electronic discovery, bankruptcy, and class action and mass tort administration. Our innovative solutions are designed to streamline the administration of litigation, investigations, financial transactions, regulatory compliance and other legal matters. Epiq’s subject-matter experts bring clarity to complexity, create efficiency through expertise and deliver confidence to our clients around the world. For more information, visit us at www.epiqsystems.com.
Press Contacts Lauren French Epiq Systems 913-815-8072 [email protected] Investor Contacts Kelly Bailey Epiq Systems 913-621-9500 [email protected] Chris Eddy Catalyst Global 212-924-9800 [email protected]


Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



